In silico analysis of TGF β1, connexin43, and galectin 3 with active components from black seed (Nigella sativa) for potential treatment of atrial fibrillation
In silico analysis of TGF β1, connexin43, and galectin 3 with active components from black seed (Nigella sativa) for potential treatment of atrial fibrillation. // In Silico Research in Biomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S3050787126005172?dgcid=rss_sd_all
In silico analysis of TGF β1, connexin43, and galectin 3 with active components from black seed (Nigella sativa) for potential treatment of atrial fibrillation. In Silico Research in Biomedicine. https://www.sciencedirect.com/science/article/pii/S3050787126005172?dgcid=rss_sd_all
“In silico analysis of TGF β1, connexin43, and galectin 3 with active components from black seed (Nigella sativa) for potential treatment of atrial fibrillation.” In Silico Research in Biomedicine.
@article{article48578,
title = {In silico analysis of TGF β1, connexin43, and galectin 3 with active components from black seed (Nigella sativa) for potential treatment of atrial fibrillation},
journal = {In Silico Research in Biomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S3050787126005172?dgcid=rss_sd_all}
}